Bone disease in CKD 5D
Laure Patrier, Elisa Del Valle(Universidad del Salvador), Jean‐Paul Cristol(Centre National de la Recherche Scientifique), L. Usvyat, Anna Saurina, Manel Ramírez de Arellano, Miquel Fulquet, K. H. Kim, Hélène Leray‐Moragues, T. Yamaguchi, Karla Yanneth Mejia Salas, B. Canaud(Université de Montpellier), Friedrich Schulze, Ángel L.M. de Francisco, A. Granger Vallee, Whitaker An, L. Chalabi, Stephan Thijssen, Adrian Covic(Grigore T. Popa University of Medicine and Pharmacy), M. Lavado, S. Fukuhara, V. Esteve, Beatrix Büschges-Seraphin, Kazuhiro Kurokawa, Marion Moréna, Mónica Pou, N. Levin, S. E. Kim, Hae-Rahn Bae, Y. Onishi, M Kroczak, Y. Park, P. Kotanko, A. Sanchez Ramos, T. Hasegawa, B. Marzell, Masafumi Fukagawa(FIND), R. Kido, A. Junque, J.-Y. Han, Laura Rosales, T. Akizawa, V. Duarte, Y. K. Son, Leïla Chénine, Jesús Macías, Annie Dupuis(University of Toronto), Jutta Passlick‐Deetjen(Fresenius Medical Care (Germany)), P. Ponce
Cited by 0
Related Papers
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
|Nephrology Dialysis Transplantation|2003|755
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
|Nephrology Dialysis Transplantation|2010|478